NCT02448758

Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²)

Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 518 (actual)
• Sponsor: Centre Oscar Lambret · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The investigators propose to create a database at the regional level, the principle is to include all patients in whom a mutation was detected from a single platform (Lille). The creation of this regional cohort, smaller than the national cohort of Biomarkers France, will perform a more comprehensive collection of clinical data, and molecular monitoring data of patients included. To increase the completeness of the collection of information, it will not be based on voluntary prescribing clinician but will be largely carried out by CRA dedicated to this activity.

Detailed description

This is a prospective and retrospective study of a population of patients with mutated non-small cell lung cancer in the Nord Pas de Calais. Retrospective cohort will involve patients with main molecular abnormalities, identifiable from molecular biology platform CRRC, except EGFR and KRAS treated from September 2011 to February 2013.

Conditions

• Non-Small Cell Lung Cancer

Timeline

• Start date: 2013-11-01
• Primary completion: 2016-09-01
• Completion: 2017-09-01
• First posted: 2015-05-19
• Last updated: 2026-03-13

Locations

2 sites across 1 country: France